Key result
Routine hsCRP testing identifies ~15% more adults at cardiovascular risk missed by lipid panels.
Why the study?
This study aimed to describe the distribution of hsCRP in Korean adults and evaluate the incremental detection of elevated hsCRP beyond lipid abnormalities using nationally representative data.
Does hsCRP measurement identify additional individuals with elevated cardiovascular risk beyond conventional lipid abnormalities in Korean adults?
Cross-Sectional (n=5,769)
Does hsCRP measurement identify additional individuals with elevated cardiovascular risk beyond conventional lipid abnormalities in Korean adults?
hsCRP testing identifies a substantial proportion of Korean adults with elevated inflammatory risk who would be missed by conventional lipid screening alone.
hsCRP may refine CV risk detection beyond lipids in Koreans; leaves open whether testing should guide therapy or improve outcomes.
Background/Objectives: This study aimed to describe the distribution of high-sensitivity C-reactive protein (hsCRP) in Korean adults and to evaluate the incremental detection of elevated hsCRP beyond lipid abnormalities using nationally representative data. Methods: We analyzed 2024 Korean National Health and Nutrition Examination Survey data from adults aged ≥ 20 years with available hsCRP and lipid measurements, excluding pregnant women. Elevated hsCRP was defined using three cutoffs: ≥1 mg/L, ≥2 mg/L, and >3 mg/L. Additional detection by hsCRP was defined as the proportion of participants without any lipid abnormality, as defined according to the NCEP ATP III criteria, who had elevated hsCRP. Results: A total of 5769 adults were included in the common hsCRP and lipid analysis population. In the survey-weighted analysis, 72.5% of participants had hsCRP < 1 mg/L, whereas 12.8%, 6.2%, 6.9%, and 1.6% had hsCRP 1 to <2, 2 to ≤3, >3 to <10, and ≥10 mg/L, respectively. The proportions of participants with hsCRP ≥1 mg/L, ≥2 mg/L, and >3 mg/L were 27.5%, 14.7%, and 8.5%, respectively. Any lipid abnormality was present in 34.4% of participants. Among 3861 participants with normal lipid profiles, elevated hsCRP was found in 22.6%, 11.7%, and 6.8%, corresponding to overall additional detection rates of 14.8%, 7.7%, and 4.4% at cutoffs of ≥1, ≥2, and >3 mg/L, respectively. Conclusions: hsCRP identified additional individuals who were not detected by conventional lipid abnormalities. These findings provide nationally representative descriptive data on hsCRP distribution and threshold-based classification in Korean adults and underscore the need for population-specific interpretation of hsCRP cutoffs.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2026) conducted a cross-sectional in Cardiovascular risk (n=5,769). High-sensitivity C-reactive protein (hsCRP) testing vs. Conventional lipid testing alone was evaluated on Additional detection rate of elevated hsCRP among participants without any lipid abnormality (at ≥1 mg/L cutoff). High-sensitivity C-reactive protein testing identified an additional 14.8%, 7.7%, and 4.4% of Korean adults at cardiovascular risk who were not detected by conventional lipid abnormalities at cutoffs of ≥1, ≥2, and >3 mg/L, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: